You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

142 Results
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-20
May 2015
Drug
Other Name(s): Navelbine®
Apr 2023
Drug
Other Name(s): Pharmorubicin PFS®
Apr 2023
Drug
Other Name(s): Alimta®
Apr 2023
Drug
Other Name(s): Provera® (multiple brands available)
Apr 2015
Drug
Other Name(s): Fludara®
Apr 2023
Drug
Other Name(s): Hycamtin®
Apr 2023
Regimen
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Neoadjuvant, Adjuvant, Palliative
Apr 2023

Pages